# Alzeca Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alzeca-biosciences

- Industry: Healthcare
- Headquarters: Houston, US
- Website: www.alzeca.com
- Total disclosed funding: $11M
- Latest round: Series A (Aug 17, 2017)
- Investors on record: 1

## About

Established in 2012 and based in Texas, US, Alzeca Biosciences, Inc. develops MRI-based imaging technologies to detect early stages of neurodegenerative diseases. In Augst 2017, the firm raised USD 11 million in Series A funding from investor Dolby Family Ventures, with participation from other investors. As of 2024, the company is headed by its CEO Carlo Medici.

The company offers imaging technologies that leverage MRI and CT scanning technologies which enables the early detection of Alzheimer’s Disease pathology. The firm technology helps to improve patient selection and monitoring of Alzheimer’s patients in clinical trials, and differential diagnosis of patients with MCI (Mild Cognitive Impairment).

## Funding rounds

- Series A, Aug 17, 2017, $11M — Dolby Family Ventures

## Investors

- Dolby Family Ventures (https://capitalatlas.ai/funds/dolby-family-ventures) — Series A